Surveillance for Colonization, Transmission, and Infection With Methicillin-Susceptible Staphylococcus aureus in a Neonatal Intensive Care Unit.
Birth Weight
Cohort Studies
Cross Infection
/ epidemiology
Disease Transmission, Infectious
/ statistics & numerical data
Female
Germany
/ epidemiology
Humans
Incidence
Infant, Newborn
Intensive Care Units, Neonatal
/ statistics & numerical data
Length of Stay
/ statistics & numerical data
Male
Nasal Cavity
/ microbiology
Odds Ratio
Population Surveillance
Staphylococcal Infections
/ epidemiology
Staphylococcus aureus
/ isolation & purification
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
13
1
2022
Statut:
epublish
Résumé
Staphylococcus aureus is one of the leading causes of infections in neonatal intensive care units (NICUs). Most studies in this patient group focus on methicillin-resistant S aureus or the outbreak setting, whereas data for methicillin-susceptible S aureus are limited. To identify risk factors for S aureus colonization and infections in hospitalized newborns and to investigate S aureus transmission and its dynamics in a nonoutbreak setting. This monocentric cohort study in a tertiary NICU in Heidelberg, Germany, enrolled all hospitalized neonates (n = 590) with at least 1 nasal screening swab positive for S aureus. Data were collected from January 1, 2018, to December 31, 2019. Weekly screening for S aureus colonization was performed for all newborns until discharge. The primary end point was any S aureus infection until hospital discharge. Transmission of S aureus and performance of routine typing to detect transmissions were defined as the secondary outcomes of the study. In total, 590 newborns were enrolled (276 [46.8%] female and 314 [53.2%] male; 220 [37.3%] with birthweight <1500 g; 477 [80.8%] preterm; 449 [76.1%] singletons; 419 [71.5%] delivered via cesarean section). The median length of stay was 26 (range, 10-62) days. Overall, 135 infants (22.9%) were colonized by S aureus at some time during their hospital stay. The median time to first detection was 17 (interquartile range, 11-37) days. The overall incidence of S aureus infection was 1.7% (10 of 590). Low birth weight (<1500 g [odds ratio, 9.3; 95% CI, 5.9-14.6; P < .001]) and longer hospital stay (odds ratio, 2.3; 95% CI, 1.9-2.7; P < .001) were associated with colonization. Nasal carriage was significantly associated with S aureus infection (odds ratio, 8.2; 95% CI, 2.1-32.3; P = .002). A total of 123 of 135 colonization isolates were sequenced. All recoverable infection isolates (4 of 7) of newborns with colonization were genetically identical to the colonizing isolate. Whole-genome sequencing indicated 23 potential transmission clusters. The findings of this cohort study suggest that nasal colonization is a relevant risk factor for S aureus infection in a nonoutbreak NICU setting. In colonized newborns, infection and colonization isolates were genetically identical, suggesting that eradication of colonization may be a useful measure to prevent infection. Further investigations are necessary to validate and assess the generalizability of our findings.
Identifiants
pubmed: 34515783
pii: 2783982
doi: 10.1001/jamanetworkopen.2021.24938
pmc: PMC8438598
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2124938Références
Pediatrics. 2012 May;129(5):e1252-9
pubmed: 22473373
Lancet Infect Dis. 2017 Feb;17(2):207-214
pubmed: 27863959
Clin Microbiol Infect. 2014 Jun;20(6):O390-6
pubmed: 24118578
J Infect Dis. 2009 Jun 15;199(12):1820-6
pubmed: 19419332
Front Microbiol. 2018 Mar 20;9:511
pubmed: 29616014
N Engl J Med. 2001 Jan 4;344(1):11-6
pubmed: 11136954
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
JAMA. 2020 Jan 28;323(4):319-328
pubmed: 31886828
Infect Control Hosp Epidemiol. 2017 Jul;38(7):883-885
pubmed: 28514970
Pediatrics. 2006 Aug;118(2):469-74
pubmed: 16882797
Int J Infect Dis. 2017 Nov;64:9-14
pubmed: 28882667
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F182-F186
pubmed: 29588296
JAMA Pediatr. 2015 Dec;169(12):1105-11
pubmed: 26502073
J Perinatol. 2021 Jun;41(6):1285-1292
pubmed: 33649431
JAMA. 2020 Jan 28;323(4):313-314
pubmed: 31886831
Clin Infect Dis. 2011 Nov;53(9):853-9
pubmed: 21878424
J Infect. 2020 May;80(5):511-518
pubmed: 32112885
Pediatr Infect Dis J. 2012 Apr;31(4):360-3
pubmed: 22189535
PLoS One. 2020 Feb 13;15(2):e0211845
pubmed: 32053585
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Microbiol Infect. 2019 Jun;25(6):739-746
pubmed: 30315958
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1745-1751
pubmed: 29943308
J Perinatol. 2014 Nov;34(11):805-10
pubmed: 25010222
Infect Control Hosp Epidemiol. 2002 Nov;23(11):677-82
pubmed: 12452296
Microb Drug Resist. 2012 Apr;18(2):116-24
pubmed: 22191392
Sci Rep. 2020 Feb 14;10(1):2619
pubmed: 32060342
Am J Infect Control. 2011 Feb;39(1):35-41
pubmed: 21281885
Sci Rep. 2020 Aug 6;10(1):13243
pubmed: 32764618
Am J Dis Child. 1978 Sep;132(9):893-6
pubmed: 685907
BMJ Open. 2016 Oct 18;6(10):e010466
pubmed: 27797978
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Sci Rep. 2017 Mar 21;7:45014
pubmed: 28322345
Antimicrob Resist Infect Control. 2014 Jul 01;3:21
pubmed: 25089196
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Clin Microbiol Infect. 2015 Jun;21(6):567.e1-10
pubmed: 25753191